While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

ITM Isotope Technologies Munich SE is gearing up to enter the US market with its radiopharmaceutical therapy, ITM-11 ...

The Danish drugmaker has launched a new online pharmacy called NovoCare Pharmacy to cut out the middlemen it so frequently ...

The US Food and Drug Administration (FDA) has approved ARS Pharmaceuticals’ neffy 1mg (epinephrine nasal spray) for treating ...

Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative ...

Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

TC BioPharm has signed a non-binding LoI to acquire a pharma company focused on commercialising intraocular pressure ...

The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union ...

Post-authorisation safety studies (PASS) are often seen simply as a regulatory necessity, a checkbox that ensures ongoing ...

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of CNS penetrant therapeutics.

Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative grows, the need for diverse data insights will affect clinical trial timelines ...

With orphan drugs typically being high value, the potential risk of stock losses should be a top concern for biotechs looking ...